Drug intelligence / Profile preview

MK-6240

Development stage
Unknown
Lead developer
Lantheus
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

XTR006 (also known as MK-6240) is an 18F-labeled small molecule radiopharmaceutical being developed by Sinotau Pharmaceutical Group (in-licensed from Cerveau Technologies) as a positron emission tomography (PET) imaging agent. It specifically targets aggregated microtubule-associated protein tau (neurofibrillary tangles), which is a hallmark pathology of Alzheimer's disease and other tauopathies. By binding to these proteins with high affinity and selectivity, XTR006 allows for the non-invasive visualization and quantification of tau burden in the brain. This diagnostic tool is intended to support the identification and monitoring of mild cognitive impairment (MCI) due to Alzheimer's disease and Alzheimer's disease dementia.

Other names
[18F]MK-624018F-MK-6240
02

Targets

MAPT (Microtubule-associated protein tau)

Beyond the preview

Go deeper on MK-6240.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MK-6240.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call